))
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
…
continue reading
1
From The Heart - (SGLT2 inhibitors) Ep#3: From diabetes to heart failure!
14:46
14:46
Play later
Play later
Lists
Like
Liked
14:46
Today’s podcast is the third in the series of five episodes of “From The Heart - Tying the threads through the evolving body of evidence in HF “. Today's episode is focused on a new class of drugs in heart failure - The Sodium Glucose Like Transporter 2 inhibitors or as they are more commonly known as SGLT2is For those who have just tuned in to our…
…
continue reading
1
Episode 1- Introduction to Consumer Healthcare and Over the Counter Drugs/Products
14:23
14:23
Play later
Play later
Lists
Like
Liked
14:23
Welcome to our new series on Consumer Healthcare and Over the Counter Drugs/Products. In the first episode we will touch upon the CHC and OTC market at a very high level, with global revenues, market leading companies and top selling brands.By RAS LSS Consulting
…
continue reading
In today´s episode, we will start with a quick history of medicine and medical practices that pre-dated the era of empirical medicine. We will then outline the major pharmaceutical breakthroughs since 1900 and how each of them has impacted our lives. And finally, in our next episode, we will round off by how we see the future of pharmaceutical inno…
…
continue reading
1
From The Heart - Ep#2: Entresto: The first ARNi approved for heart failure
11:11
11:11
Play later
Play later
Lists
Like
Liked
11:11
Today’s podcast is the second in the series of five episodes of “From The Heart - Tying the threads through the evolving body of evidence in HF “. Today's episode is focused on understanding Entresto's mechanism, clinical trials, patient population and clinical benefits. For those who have just tuned in to our podcast series for the first time, ple…
…
continue reading
1
From The Heart - Ep#1: Introduction to Heart Failure and A brief overview of evolving HF treatments
9:25
9:25
Play later
Play later
Lists
Like
Liked
9:25
Today’s podcast is the first in the series of five episodes of “From The Heart - Tying the threads through the evolving body of evidence in HF “. In this first episode we will discuss the diagnosis and treatment of heart failure. We will also talk about the pharmaceutical innovations in the last ten years and how they are changing the standard of c…
…
continue reading
In today’s episode, we will start with a quick introduction to Immuno-Oncology. We will then look in to the evolution of this concept followed by the current situation and finally, we will touch briefly on the road-ahead for Immuno-Oncology. We would love to hear from our audiences on which Immuno-oncology therapies you think have shaped today's tr…
…
continue reading
1
Introduction to Market Intelligence and its Relevance to Pharmaceutical Industry
14:48
14:48
Play later
Play later
Lists
Like
Liked
14:48
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all t…
…
continue reading
